1. Home
  2. ARTNA vs CABA Comparison

ARTNA vs CABA Comparison

Compare ARTNA & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$31.87

Market Cap

344.1M

Sector

Utilities

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.07

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTNA
CABA
Founded
1905
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.1M
319.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ARTNA
CABA
Price
$31.87
$3.07
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$14.50
AVG Volume (30 Days)
64.5K
1.9M
Earning Date
05-04-2026
05-14-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.82
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
$15.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.50
$1.01
52 Week High
$36.19
$3.78

Technical Indicators

Market Signals
Indicator
ARTNA
CABA
Relative Strength Index (RSI) 46.03 53.59
Support Level $31.35 $2.11
Resistance Level $32.34 $3.34
Average True Range (ATR) 0.81 0.24
MACD 0.07 0.01
Stochastic Oscillator 62.05 72.33

Price Performance

Historical Comparison
ARTNA
CABA

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: